Coenzyme Q10: A therapy for hypertension and statin-induced myalgia?
@article{Wyman2010CoenzymeQA, title={Coenzyme Q10: A therapy for hypertension and statin-induced myalgia?}, author={Marcia J. Wyman and Mandy C. Leonard and Thomas J. Morledge}, journal={Cleveland Clinic Journal of Medicine}, year={2010}, volume={77}, pages={435 - 442} }
Some small clinical trials seem to show that coenzyme Q10 supplements can be used to lower blood pressure and to treat or prevent myalgia caused by hydroxymethylglutaryl coenzyme A reductase inhibitors (statins). However, larger trials are needed to determine if they are truly effective for these purposes. The authors examine the evidence and also discuss issues such as bioavailability, elimination, safety, and cost. These supplements appear to be safe, but larger trials are needed to determine…
Tables from this paper
55 Citations
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials.
- MedicineMayo Clinic proceedings
- 2015
Coenzyme Q10: Clinical Update and Bioavailability
- Medicine, Biology
- 2011
A review of clinical efficacy trials using CoQ10 is provided and recent advances in formulation technology to improve the bioavailability of CoQ 10 are described to help clinicians and consumers make informed decisions.
Effects of Coenzyme Q 10 on Statin-Induced Myopathy : A Meta-analysis of Randomized Controlled Trials
- Medicine
- 2014
The results of this meta-analysis of available randomized controlled trials do not suggest any significant benefit of CoQ10 supplementation in improving statin-induced myopathy and larger, welldesigned trials are necessary to confirm the findings.
Coenzyme Q10 Supplementation Decreases Statin-Related Mild-to-Moderate Muscle Symptoms: A Randomized Clinical Study
- MedicineMedical science monitor : international medical journal of experimental and clinical research
- 2014
Results show that coenzyme Q10 supplementation (50 mg twice daily) effectively reduced statin-related mild-to-moderate muscular symptoms, causing lower interference of statin -related muscular symptoms with daily activities.
Genetic and immunologic susceptibility to statin-related myopathy.
- Biology, MedicineAtherosclerosis
- 2015
Application of Coenzyme Q 10 in Clinical Practice
- Biology
- 2018
Emerging evidence supports that administration of CoQ10 may have beneficial effects at the mitochondrial level and the cellular mechanisms of Co Q10 and the administration ofCoQ10 in different clinical disease states are emphasized.
Addition of omega-3 fatty acid and coenzyme Q10 to statin therapy in patients with combined dyslipidemia
- BiologyJournal of basic and clinical physiology and pharmacology
- 2017
The results of this pilot study suggest the possible beneficial effects of triple combination on the lipid and non-lipid parameters related to atherogenesis and side effects of statin treatment.
Application of Coenzyme Q10 in Clinical Practice
- Biology
- 2012
Emerging evidence supports that administration of CoQ10 may have beneficial effects at the mitochondrial level and the cellular mechanisms of Co Q10 and the administration ofCoQ10 in different clinical disease states are emphasized.
Reversal of statin-induced memory dysfunction by co-enzyme Q10: a case report
- MedicineVascular health and risk management
- 2015
It is being recommended for use for use when statin side effects (muscle- and memory-related) impair quality of life and leave patient at dyslipidemia-induced cardiovascular morbi-mortality.
References
SHOWING 1-10 OF 51 REFERENCES
Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.
- MedicineThe American journal of cardiology
- 2007
Effect of coenzyme q10 on myopathic symptoms in patients treated with statins.
- MedicineThe American journal of cardiology
- 2007
The role of coenzyme Q10 in statin-associated myopathy: a systematic review.
- MedicineJournal of the American College of Cardiology
- 2007
Statin myopathy: Incidence, risk factors, and pathophysiology
- Biology, MedicineCurrent atherosclerosis reports
- 2007
The development of a standardized system for description and documentation of statin-associated myopathy that includes the entire spectrum of muscle complaints would provide valuable data for researchers and clinicians seeking to better understandstatin-induced muscle complaints.
Coenzyme Q10 supplementation and heart failure.
- Medicine, BiologyNutrition reviews
- 2007
There is evidence to support the therapeutic value of CoQ10 as an adjunct to standard medical therapy in congestive heart failure, however, much further research is required, especially in the use of state-of-the-art techniques to assess functional outcomes in patients with congestiveheart failure.
Lovastatin decreases coenzyme Q levels in humans.
- Biology, MedicineProceedings of the National Academy of Sciences of the United States of America
- 1990
Data from the three protocols revealed that lovastatin does indeed lower levels of CoQ10, and this reduction would constitute a new risk of cardiac disease, since it is established that Co Q10 is indispensable for cardiac function.
Effect of Ezetimibe and/or Simvastatin on Coenzyme Q10 Levels in Plasma
- BiologyDrug safety
- 2006
There is a significant correlation between the CoQ10 level decrease and the decrease in total and LDL-C levels in all three treatment groups, suggesting that the Co Q10 decrease may reflect the decreaseIn the levels of its lipoprotein carriers and might not be statin-specific.
Safety assessment of coenzyme Q10 (CoQ10)
- MedicineBioFactors
- 2008
The use of CoQ10 as a dietary supplement has grown with a corresponding increase in daily dosage, and its physiological function is to act as an essential cofactor for ATP production, and to perform important antioxidant activities in the body.
Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease
- MedicineJournal of Human Hypertension
- 1999
It is indicated that treatment with coenzyme q10 decreases blood pressure possibly by decreasing oxidative stress and insulin response in patients with known hypertension receiving conventional antihypertensive drugs.